Расширенный поиск

Роль малых дыхательных путей при бронхиальной астме

Полный текст:

Об авторе

С. Н. Авдеев


Список литературы

1. Mannino D.M., Homa D.M., Akinbami L.I. et al. Surveil� lance of asthma - United States, 1980-1990. Morb. Mort. Wkly Rep. Surveill. Summ. 2002; 51: 1-13

2. Global initiative for asthma: Global strategy for asthma management and prevention. NHLBI / WHO Workshop Report. Updated 2009. Available at: http://www.ginasthma. com

3. Bateman E.D., Boushey H.A., Bousquet J. et al. Can guide� line�defined asthma control be achieved? The gaining opti� mal asthma control study. Am. J. Respir. Crit. Care Med. 2004; 170: 836-844

4. Morgan W.J., Stern D.A., Sherrill D.L. et al. Outcome of asthma and wheezing in the first 6 years of life: follow�up through adolescence. Am. J. Respir. Crit. Care Med. 2005; 172: 1253-1258

5. Van Ganse E., Laforest L., Pietri G. et al. Persistent asthma: disease control, resource utilisation and direct costs. Eur. Respir. J. 2002; 20: 260-267

6. Van Ganse E., Antonicelli L., Zhang Q. et al. Asthma�related resource use and cost by GINA classification of severity in three European countries. Respir. Med. 2006; 100: 140-147

7. Burgel P.R., de Blic J., Chanez P. et al. Update on the roles of distal airways in asthma. Eur. Respir. Rev. 2009; 18: 80-95

8. Hyde D.M., Hamid Q., Irvin C.G. Anatomy, pathology, and physiology of the tracheobronchial tree: emphasis on the distal airways. J. Allergy Clin. Immunol. 2009; 124: 72-77

9. Contoli M., Bousquet J., Fabbri L.M. et al. The small airways and distal lung compartment in asthma and COPD: a time for reappraisal. Allergy 2010; 65: 141-151

10. Weibel E.R. Morphometry of the human lung. New York: Academic Press; 1963

11. Wright J.L. Small airway diseases: its role in chronic airway obstruction. Semin. Respir. Med. 1992; 13: 72-84

12. Garg K., Lynch D.A., Newell J.D., King T.E. Proliferative and constrictive bronchiolitis: classification and radiological features. Am. J. Roentgenol. 1994; 162: 803-808

13. Macklem P.T., Mead J. Resistance of central and peripheral airways measured by a retrograde catheter. J. Appl. Physiol. 1967, 22: 395-401

14. Macklem P.T., Mead J. Factors determining maximum expiratory flow in dogs. J. Appl. Physiol. 1968, 25: 159-169

15. Van Brabandt H., Cauberghs M., Verbeken E. et al. Partitioning of pulmonary impedance in excised human and canine lungs. J. Appl. Physiol. 1983, 55: 1733-1742

16. Wagner E.M., Liu M.C., Weinmann G.G. et al. Peripheral lung resistance in normal and asthmatic subjects. Am. Rev. Respir. Dis. 1990; 148: 584-588

17. Wagner E.M., Bleecker E.R., Permutt S. et al. Direct assess� ment of small airways reactivity in human subjects. Am. J. Respir. Crit. Care Med. 1998; 157: 447-452

18. Yanai M., Sekizawa K., Ohrui T. et al. Site of airway obstruc� tion in pulmonary disease: direct measurement of intra� bronchial partition the central and peripheral airway resist� ance in a pressure. J. Appl. Physiol. 1992; 72: 1016-1023

19. Gibson G.J. Pulmonary hyperinflation a clinical overview. Eur. Respir. J. 1996; 9: 2640-2649

20. Sorkness R.L., Bleecker E.R., Busse W.W. et al. Lung func� tion in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J. Appl. Physiol. 2008; 104: 394-403

21. Wenzel S.E., Schwartz L.B., Langmack E.L. et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am. J. Respir. Crit. Care Med. 1999; 160: 1001-1008

22. Marseglia G.L., Cirillo I., Vizzaccaro A. et al. Role of forced expiratory flow at 25-75 % as an early marker of small air� ways impairment in subjects with allergic rhinitis. Allergy Asthma Proc. 2007; 28: 74-78

23. Hansen J.E., Sun X.G., Wasserman K. Discriminating meas� ures and normal values for expiratory obstruction. Chest 2006; 129: 369-377

24. Pellegrino R., Viegi G., Brusasco V. et al. Interpretative strategies for lung function tests. Eur. Respir. J. 2005; 26: 948-968

25. Bourdin A., Paganin F., Prefaut C. et al. Nitrogen washout slope in poorly controlled asthma. Allergy 2006; 61: 85-89

26. Make B., Lapp N.L. Factors influencing the measurement of closing volume. Am. Rev. Respir. Dis. 1975; 111: 749-754

27. McFadden E.R., Holmes B., Kiser R. Variability of closing volume measurements in normal man. Am. Rev. Respir. Dis. 1975; 111: 135-140

28. Antic R., Macklem P.T. The influence of clinical factors on the site of airway obstruction in asthma. Am. Rev. Respir. Dis. 1976; 114: 851-859

29. Berend N., Nelson A., Rutland M.B. et al. The maximum expiratory flow�volume curve with air and a low�density gas mixture. An analysis of subject and observer variability. Chest 1981; 80: 23-30

30. Zack R.T., Solliday N.H., Celik L. et al. Variability of the volume of isoflow. Chest 1981; 79: 269-272

31. Saadeh C., Goldman M., Gaylor P. Forced oscillation using impulse oscillometry (IOS) detects false negative spirometry in symptomatic patients with reactive airways. J. Allergy Clin. Immun. 2003; 111: 136

32. Landser F.J., Clement J., Van de Woestijne K.P. Normal val� ues of total respiratory resistance and reactance determined by forced oscillations: influence of smoking. Chest 1982; 81: 586-591

33. Mahut B., Delacourt C., ZerahLancner F. et al. Increase in alveolar nitric oxide in the presence of symptoms in child� hood asthma. Chest 2004; 125: 1012-1018

34. Battaglia S., den Hertog H., Timmers M.C. et al. Small air� ways function and molecular markers in exhaled air in mild asthma. Thorax 2005; 60: 639-644

35. King G.G., Muller N.L., Par P.D. Evaluation of airways in obstructive pulmonary disease using high�resolution com� puted tomography. Am. J. Respir. Crit. Care Med. 1999; 159: 992-1004

36. Lynch D.A., Newell J.D., Tschomper B.A. et al. Uncompli� cated asthma in adults: comparison of CT appearance of the lungs in asthmatic and healthy subjects. Radiology 1993; 188: 829-833

37. Park J.W., Hong Y.K., Kim C.W. et al. High�resolution com� puted tomography in patients with bronchial asthma: corre� lation with clinical features, pulmonary functions and bronchial hyperresponsiveness. J. Investig. Allergol. Clin. Immunol. 1997; 7: 186-192

38. McNittGray M.F., Goldin J.G., Johnson T.D. et al. Development and testing of image�processing methods for the quantitative assessment of airway hyperresponsiveness from high�resolution CT images. J. Comput. Assist. Tomogr. 1997; 21: 939-947

39. Goldin J.G., McNittGray M.F., Sorenson S.M. et al. Airway hyperreactivity assessment with helical thin�section C. Radiology 1998; 208: 321-329

40. Goldin J.G., McNittGray M.F. Johnson T. et al. Functional helical high�resolution CT: sensitive test for detecting air trapping due to reversible airway hyperreactivity. Radiology 1995; 197 (P): 437

41. Laurent F., Latrabe V., Raherison C. et al. Functional signif� icance of air trapping detected in moderate asthma. Eur. Radiol. 2000; 10: 1404-1410

42. Jensen S.P., Lynch D.A., Brown K.K. et al. High�resolution CT features of severe asthma and bronchiolitis obliterans. Clin. Radiol. 2002; 57: 1078-1085

43. Ueda T., Niimi A., Matsumoto H. et al. Role of small airways in asthma: investigation using high�resolution computed tomog� raphy. J. Allergy Clin. Immunol. 2006; 118: 1019-1025

44. Jain N., Covar R.A., Gleason M.C. et al. Quantitative com� puted tomography detects peripheral airway disease in asth� matic children. Pediatr. Pulmonol. 2005; 40: 211-218

45. Lee Y.M., Park J.S., Hwang J.H. et al. High�resolution CT findings in patients with near�fatal asthma: comparison of patients with mild�to�severe asthma and normal control subjects and changes in airway abnormalities following steroid treatment. Chest 2004; 126: 1840-1848

46. Goldin J.G.,Tashkin D.P., Kleerup E.C. et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin�section computed tomography. J. Allergy Clin. Immunol. 1999; 104: 258-267

47. Yablonskiy D.A., Sukstanskii A.L., Leawoods J.C. et al. Quantitative in vivo assessment of lung microstructure at the alveolar level with hyperpolarized 3He diffusion MRI. Proc. Natl. Acad. Sci. USA 2002; 99: 3111-3116

48. Samee S., Altes T., Powers P. et al. Imaging the lungs in asth� matic patients by using hyperpolarized helium�3 magnetic resonance: assessment of response to methacholine and exercise challenge. J. Allergy Clin. Immunol. 2003; 111: 1205-1211

49. Kauczor H.U., Chen X.J., van Beek E.J., Schreiber W.G. Pulmonary ventilation imaged bymagnetic resonance: at the doorstep of clinical application. Eur. Respir. J. 2001; 17: 1008-1023

50. de Lange E.E., Altes T.A., Patrie J.T. et al. Evaluation of asthma with hyperpolarized helium�3 MRI: correlation with clinical severity and spirometry. Chest 2006; 130: 1055-1062

51. Holz O., Jorres R.A., Magnussen H. Monitoring central and peripheral airway inflammation in asthma. Respir. Med. 2000; 94 (Suppl. D): 7-12

52. Huber H.L., Koessle K. The pathology of bronchial asthma. Arch. Intern. Med. 1922; 30: 689-760

53. Saetta M., DeStefano A., Rosina C. et al. Quantitative struc� tural analysis of peripheral airways and arteries in sudden fatal asthma. Am. Rev. Respir. Dis. 1991; 143: 138-143

54. Kuwano K., Bosken C.H., Pare P.D. et al. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1993; 148: 1220-1225

55. Haley K.J., Sunday M.E., Wiggs B.R. et al. Inflammatory cell distribution within and along asthmatic airways. Am. J. Respir. Crit. Care Med. 1998; 158: 565-572

56. de Magalhäes Simöes S., dos Santos M.A. et al. Inflammatory cell mapping of the respiratory tract in fatal asthma. Clin. Exp. Allergy 2005; 35: 602-611

57. de Medeiros Matsushita M., da Silva L.F., dos Santos M.A. et al. Airway proteoglycans are differentially altered in fatal asth� ma. J. Pathol. 2005; 207: 102-110

58. Dolhnikoff M., da Silva L.F., de Araujo B.B. et al. The outer wall of small airways is a major site of remodeling in fatal asthma. J. Allergy Clin. Immunol. 2009; 123: 1090-1097

59. Mauad T., Silva L.F., Santos M.A. et al. Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. Am. J. Respir. Crit. Care Med. 2004; 170: 857-862

60. Shiang C., Mauad T., Senhorini A. et al. Pulmonary periar� terial inflammation in fatal asthma. Clin. Exp. Allergy 2009; 39: 1499-1507

61. Hamid Q., Song Y., Kotsimbos T.C. et al. Inflammation of small airways in asthma. J. Allergy Clin. Immunol. 1997; 100: 44-51

62. Hamid Q. Peripheral inflammation is more important than central inflammation. Respir. Med. 1997: 91 (Suppl. A): 11-12

63. Kraft M., Djukanovic R., Wilson S. et al. Alveolar tissue inflammation in asthma. Am. J. Respir. Crit. Care Med. 1996; 154: 1505-1510

64. McFadden E.R., Kiser R., DeGroot W.J. Acute bronchial asthma. Relations between clinical and physiologic meas� ures. N. Engl. J. Med. 1973; 288: 221-225

65. Kraft M., Pak J., Martin R.J. et al. Distal lung dysfunction at night in nocturnal asthma. Am. J. Respir. Crit. Care Med. 2001; 163: 1551-1556

66. Lange P., Parner J., Vestbo J. et al. A 15�year follow�up study of ventilatory function in adults with asthma. N. Engl. J. Med. 1998; 339: 1194-1200

67. Peat J.K., Woolcock A.J., Culle K. Rate of decline of lung function in subjects with asthma. Eur. J. Respir. Dis. 1987; 70: 171-179

68. in't Veen J.C., Beekman A.J., Bel E.H. et al. Recurrent exac� erbations in severe asthma are associated with enhanced air� way closure during stable episodes. Am. J. Respir. Crit. Care Med. 2000; 161: 1902-1906

69. van Veen I.H., Sterk P.J., Schot R. et al. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur. Respir. J. 2006; 27: 951-956

70. Leach C.L. Improved delivery of inhaled steroids to the large and small airways. Respir. Med. 1998; 92 (Suppl. A): 3-8

71. Lipworth B.J. Targets for inhaled drugs. Respir. Med. 2000; 94 (Suppl. D): S13-S16

72. Worth H., Muir J.F., Pieters W.R. Comparison of hydroflu� oroalkane�beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control. Respiration 2001; 68: 517-526

73. Reichel W., Dahl R., Ringdal N. et al. Extrafine beclometha� sone dipropionate breath�actuated inhaler (400 micrograms / day) versus budesonide dry powder inhaler (800 micrograms / day) in asthma. Int. J. Clin. Pract. 2001; 55: 100-106

74. Ederle K. Multicentre Study Group. Improved control of asthma symptoms with a reduced dose of HFA�BDP extrafine aerosol: an open�label, randomised study. Eur. Rev. Med. Pharmacol. Sci. 2003; 7: 45-55

75. Davies R.J., Stampone P., O'Connor B.J. Hydrofluoro� alkane�134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose. Respir. Med. 1998; 92 (Suppl. A): 23-31

76. Hampel F., Lisberg E., Guerin J.C. Effectiveness of low doses (50 and 100 μg b.i.d) of beclomethasone dipropionate deliv� ered as a CFC�free extrafine aerosol in adults with mild to moderate asthma. Study Group. J. Asthma 2000; 37: 389-398

77. Fowler S.J., Currie G.P., Lipworth B.J. Step�down therapy with low�dose fluticasone�salmeterol combination or medi� um�dose hydrofluoroalkane 134a�beclomethasone alone. J. Allergy Clin. Immunol. 2002; 109: 929-935

78. Molimard M., Martinat Y., Rogeaux Y. et al. Improvement of asthma control with beclomethasone extrafine aerosol com� pared to fluticasone and budesonide. Respir. Med. 2005; 99: 770-778

79. Busse W.W., Brazinsky S., Jacobson K. et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is propor� tional to dose and is improved by formulation with a new pro� pellant. J. Allergy Clin. Immunol. 1999; 104: 1215-1222

80. Goldin J.G., Tashkin D.P., Kleerup E.C. et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin�section computed tomography. J. Allergy Clin. Immunol. 1999; 104: 258-267

81. Hampel F., Lisberg E., Guerin J.C. Effectiveness of low doses (50 and 100 μg b.i.d) of beclomethasone dipropionate deliv� ered as a CFC�free extrafine aerosol in adults with mild to moderate asthma. Study Group. J. Asthma 2000: 37 (5): 389-398

82. Ohbayashi H. One�year evaluation of the preventative effect of hydrofluoroalkane�beclomethasone dipropionate on eosinophilic inflammation of asthmatic peripheral airways. Respiration 2007: 74: 146-153

83. Dhillon S., Keating G.M. Beclometasone dipropionate / for� motherol. In an HFA�propelled pressurized metered�dose inhaler. Drugs 2006; 66: 1475-1483

84. Bousquet J., Poli G., Acerbi D. et al. Systemic exposure and implications for lung deposition with extra�fine HFA beclometasone dipropionat / formoterol fixed combination. Clin. Pharmacokinet. 2009; 48: 347-358

85. De Backer W., Devolder A., Poli G. et al. Lung deposition of BDP / formoterol HFA pMDI in healthy volunteers, asth� matic, and COPD patients. J. Aerosol Med. Pulm. Drug Deliv. 2010; 23: 137-148

86. BonnetGonod F., Kottakis I., Ballabio M. et al. Superior efficacy of a low daily dose of a new fixed combination of beclometasone dipropionate / formoterol pMDI compared to an increased daily dose of BDP in moderate persistent asthma: a 3 month clinical study. 16th Annual Congress of the European Respiratory Society; 2006 Sep. 2-6; Munich: P1237

87. Huchon G., Magnussen H., Chuchalin A. et al. Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir. Med. 2009; 103: 41-49

88. Scichilone N., Battaglia S., Sorino C. et al. Effects of extra� fine inhaled beclomethasone / formoterol on both large and small airways in asthma. Allergy 2010; 65: 897-902

89. Papi A., Paggiaro P., Nicolini G. et al. Beclomethasone / for� moterol vs fluticasone / salmeterol inhaled combination in moderate to severe asthma. Allergy 2007; 62: 1182-1188

90. Papi A., Paggiaro P.L., Nicolini G. et al. Beclomethasone / formoterol versus budesonide / formoterol combination therapy in asthma. Eur. Respir. J. 2007; 29: 682-689

Для цитирования:

Авдеев С.Н. Роль малых дыхательных путей при бронхиальной астме. Пульмонология. 2010;(6):87-97.

Просмотров: 8

ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)